SavorEat Agrees to Hand Over Control for NIS 7 Million

If the investment closes, SavorEat will receive NIS 7 million and resolve its immediate funding problem, but existing shareholders will retain only about 35% before the investors exercise any options. Only NIS 2.6 million of the investment is earmarked for the existing foodtech operation, together with whatever cash remains after deducting liabilities incurred through closing. The balance of the investment is intended for a new income-producing real-estate activity in Europe. The options that could lift the investor group’s stake to 72.2% are also tied to property purchases, not revenue, customers, or Robot Chef commercialization. The transaction improves the existing operation’s survival odds but provides no new evidence of product demand. It is a signed, binding agreement, yet shareholder approval and other conditions remain outstanding, making closing, the net amount placed in the foodtech account, and the accompanying spending plan the next proof points.

NIS 7 Million Comes In, Only NIS 2.6 Million Goes to Foodtech

The use of proceeds is more revealing than the financing headline. NIS 2.6 million will be transferred to a separate account reserved for the existing operation. That account will also receive the cash held at closing after deducting all debts and liabilities arising before that date. The remaining NIS 4.4 million, before the separately disclosed transaction fee, is designated for the new real-estate activity.

The Company ended 2025 with NIS 2.747 million in cash after using NIS 7.487 million in operating activities during the year. Management then estimated that cost cuts could support operations through December 2026, or October if shutdown costs became necessary. Those figures do not establish the new runway: spending has changed, the current cash balance is undisclosed, and only cash left after settling or deducting liabilities will enter the separate account.

The relevant measure is the foodtech operation’s all-in cash flexibility, meaning cash available after real obligations and payments rather than the gross investment amount. There is no recurring cash-generating operation that can support a normalized cash-generation calculation.

The compensation note adds an important constraint. Beginning in April 2025, part of management and director compensation was deferred and accumulated as unsecured debt, payable by the end of 2026 or earlier following an equity raise, termination, or a material transaction. The new filing does not quantify the accumulated amount. Some existing cash could therefore be required for payment before the balance transferred to the legacy-operation account is determined.

Future spending also needs clarification. At closing, the CEO will leave that position and manage the existing operation as a consultant for NIS 75,000 per month plus VAT. A full year at that rate equals NIS 900,000, roughly 35% of the newly earmarked foodtech amount, before employee, adviser, technology-maintenance, and commercialization costs. The separate account buys time, but its duration depends on a spending plan that has not been disclosed.

Control and Options Point Toward Real Estate

The five controlling holders within the group are expected to own 47.2% together through their holdings and voting agreement. The other group members bring the total investor allocation to 64%. The entire board, other than the external directors, will be replaced by nominees of Itay Moldavsky and David Maimon. The change also contemplates an active chair, an active vice-chair, and an internal legal adviser related to one of the controlling holders, subject to the required approvals.

The option conditions make the incentive structure explicit. Series A and B exercises do not depend on a binding Robot Chef contract, first revenue, or another foodtech operating milestone. They depend on acquiring European properties and leasing them to third parties. The legacy operation remains in a separate account, while additional investor ownership is earned through development of the new business.

The issue price is approximately NIS 1.60 per share, compared with a NIS 3.50 closing price on July 15, a gap of about 54%. This is not a clean valuation comparison: the investors receive control, options, and influence over a change in business, while the quoted price also reflects thin trading and transaction expectations. The gap does not establish that the shares are cheap or expensive, but it illustrates the cost of bringing committed capital into the Company.

The Agreement Is Binding, but the Cash Has Not Closed

The investors committed jointly and severally, with mutual guarantees, to fund the investment. The disclosure does not include an escrow deposit, bank guarantee, or financial information that would allow readers to assess the group’s funding capacity. At this stage, the signed agreement and closing mechanics carry more weight than an assumption that the cash is already available.

Closing requires shareholder approval by the applicable majority, TASE approval to list the shares and option shares, no legal prohibition, no material adverse change, regulatory and third-party approvals where required, and no additional maintenance-list cause beyond the public-holdings-value issue. The conditions are scheduled to be satisfied within 60 days of signing. Either party may extend that period by another 30 days.

If the conditions are not satisfied and no permitted extension or waiver applies, the agreement expires. The legacy operation’s funding problem would then return to the center of the analysis because the latest annual statements contained substantial doubt about the Company’s ability to continue without additional capital.

Millennium Retains a Small, Diluted Exposure

At the end of 2025, Millennium Food-Tech held 12.5% on a fully diluted basis. The position had a fair value of NIS 641,000 within a NIS 56.766 million investment portfolio, making it only about 1.1% of the portfolio. Its carrying value was based on the quoted share price rather than an independent valuation of the foodtech operation.

If the transaction closes, the existing shareholder base will shrink to roughly 35% of the Company. A simple calculation, assuming no other capital change, puts Millennium’s stake near 4% to 5% before the new investors exercise their options. Option exercises could dilute it further. The percentage decline does not by itself determine investment value because the Company receives cash and adds a new activity. The eventual value will depend on capital deployment, acquired assets, and the value retained in foodtech.

For Millennium, the event mainly clarifies the quality of its exposure. A position that was already small within the portfolio changes from a focused foodtech holding into a diluted interest in a listed vehicle combining foodtech and real estate.

Conclusion

The transaction is primarily survival financing and a transfer of control. It creates a dedicated account for foodtech and avoids immediate abandonment of the technology, but most new capital, governance power, and future incentives point toward building a real-estate business. The agreement therefore cannot be treated as commercial validation of the product or evidence that the revenue path has improved.

The read will change only after three disclosures: shareholder approval and closing, the net cash balance transferred to the legacy account, and a spending plan connecting monthly costs to a measurable commercial target. Until then, the financing improves continuity prospects at the price of deep dilution and a shift in the center of value toward a new activity that has yet to acquire an asset.